We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Application Connects Point-of-Care Coordinators via Tablet or Smartphone

By LabMedica International staff writers
Posted on 29 Apr 2016
Print article
Image: The cobas IT 1000 connectivity system (Photo courtesy of Roche).
Image: The cobas IT 1000 connectivity system (Photo courtesy of Roche).
A new mobile application has been released that allows point-of-care coordinators (POCCs) and laboratory supervisors to control operations from any location.

Modern-day laboratories face modern-day challenges. It is a constant quest to achieve the balance between quality of results and services, speed of result delivery and cost-effectiveness of operations. A critical aspect in laboratory operations is the proper management of information technology – the flow of patients’ clinical data and information.

To meet the demand for a more streamlined flow of information, Roche (Basel, Switzerland) developed the cobas infinity Point-of-Care mobile application. This app is available for iOS and Android devices and works on smartphones and tablets in conjunction with the Roche cobas IT 1000 program.

The app provides interoperability across the full Roche POC portfolio including Accu-Chek Inform II, CoaguChek XS Plus and Pro, cobas h 232, cobas b 101, Urisys 1100, cobas b 121, cobas b 123, and cobas b 221 for diverse clinical disciplines, such as clinical chemistry, immunology, hematology, coagulation and urinalysis.

“From the outset, the app was designed with the POCC in mind,” said Georgios Spitadakis, lifecycle leader for workflow and IT at Roche. “The cobas infinity POC mobile is not just PC software on a smaller screen or with a different design. It has been designed by POCCs for POCCs to help them carry out their most essential routine tasks efficiently and easily with a mobile device.”

Related Links:
Roche

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.